Labcorp Holdings Inc. (LH)
As of Sep 20, 2026, Labcorp Holdings Inc. (LH) scores 6.6/10 on AlphaStocks' five-model composite, #22 of 168 Health Care stocks. At $320, LH trades 30% above its model fair value of $246.
Health Care / Health Care Services
S&P 500$320.37
Middle of the pack. No strong signal either way.
Consider Buy
Score based on 5 of 5 models — high confidence
Data as of Sep 20, 2026
Is LABCORP HOLDINGS INC. a Good Investment in 2026?
LABCORP HOLDINGS INC. (LH) scores 6.6 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates LABCORP HOLDINGS INC. as Strong (8/9). However, the Graham model rates it Caution — 78% above fair value. LABCORP HOLDINGS INC. currently trades 30% above its estimated fair value of $246. LABCORP HOLDINGS INC. ranks #22 out of 168 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading above estimated fair value — the market may be pricing in future growth.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Strong
8/9
Buffett
Attractive
Business quality & competitive moat
Graham
Caution
78% above fair value
Lynch
Neutral
High PEG — growth premium · Slow Grower
Greenblatt
Strong
Earnings yield 8.1% · ROC 53%
Frequently Asked Questions
Is LABCORP HOLDINGS INC. (LH) a good investment?
What is LABCORP HOLDINGS INC.'s Piotroski F-Score?
Is LH overvalued or undervalued?
How does LH compare to other Health Care stocks?
What do investment models say about LH?
Similar Stocks
Compare LH with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer